TY - JOUR
T1 - Combined effects of ischemic preconditioning and nitrate supplementation on submaximal cycling exercise and time-trial performance
AU - McIlvenna, Luke C.
AU - Monaghan, Chris
AU - Fernandez, Bernadette O.
AU - Feelisch, Martin
AU - Muggeridge, David
AU - Easton, Chris
PY - 2016/5
Y1 - 2016/5
N2 - Ischemic preconditioning (IPC) and dietary nitrate
supplementation (DN) have both been shown to modulate nitric oxide (NO)
availability. Despite the possibility of a synergistic response, the combined
effects of IPC and DN during exercise have yet to be explored.
PURPOSE: To determine the effects of IPC alone and in
combination with DN on the physiological responses to submaximal cycling and
time trial (TT) performance.
METHODS: Following an initial maximal exercise test,
nine competitive male cyclists (34 ± 6 Yr, V[Combining Dot Above]O2peak:
55 ± 4 mL/kg/min) completed a baseline trial (BASE), and two experimental
trials in a double-blind randomized cross-over design. Exercise trials
comprised 6 min of cycling at 80% of the ventilatory threshold, followed by a
16.1 km TT. In the experimental trials participants received either 500 mg of
DN (chard gel) or a NO3--depleted placebo (PLA) 90 min
before completing three cycles of bilateral lower limb IPC at 180 mmHg. Venous
blood samples were collected pre- and post-IPC to determine changes in plasma
nitrite [NO2-]. V[Combining Dot Above]O2 and
HR were continuously monitored during submaximal exercise.
RESULTS: Full arterial occlusion was confirmed via
coloured Doppler in all trials. Prior to IPC, plasma [NO2-]
was higher in DN (774 ± 179 nM, P=0.047) than BASE (576 ± 170 nM)
and PLA (544 ± 126 nM, P=0.752). Following IPC plasma [NO2-]
increased in PLA (Δ104 ± 149 nM, d=0.70) and DN (Δ42 ± 90 nM, d=0.47),
but not significantly (both P>0.2). In the DN trial, resting
V[Combining Dot Above]O2 was significantly lower compared to
BASE (314 ± 69 vs. 367 ± 30 mL/min, P=0.02) and tended to be lower
during exercise (P=0.066). Resting V[Combining Dot Above]O2 was
also lower in PLA than BASE (323 ± 62 mL/min, P=0.01) and during exercise (2783
± 262 vs. 3013 ± 342 mL/min, P=0.04). HR was not significantly
different in submaximal exercise (P=0.842). Completion time of TT was
not different between conditions (BASE: 1336 ± 73 s, PLA: 1344 ± 88 s, DN: 1344
± 76 s, P=0.69). Compared to BASE (171 ± 4 bpm), HR was lower
following DN (166 ± 4 bpm, P=0.02) but was not different in PLA
(169 ± 4 bpm, P=0.60).
CONCLUSION: In the present study, IPC with or without
DN, altered a number of physiological responses during rest and submaximal
exercise, potentially mediated by an increase in plasma [NO2-].
Despite this, there was no evidence for an additive effect and neither
intervention altered TT performance.
AB - Ischemic preconditioning (IPC) and dietary nitrate
supplementation (DN) have both been shown to modulate nitric oxide (NO)
availability. Despite the possibility of a synergistic response, the combined
effects of IPC and DN during exercise have yet to be explored.
PURPOSE: To determine the effects of IPC alone and in
combination with DN on the physiological responses to submaximal cycling and
time trial (TT) performance.
METHODS: Following an initial maximal exercise test,
nine competitive male cyclists (34 ± 6 Yr, V[Combining Dot Above]O2peak:
55 ± 4 mL/kg/min) completed a baseline trial (BASE), and two experimental
trials in a double-blind randomized cross-over design. Exercise trials
comprised 6 min of cycling at 80% of the ventilatory threshold, followed by a
16.1 km TT. In the experimental trials participants received either 500 mg of
DN (chard gel) or a NO3--depleted placebo (PLA) 90 min
before completing three cycles of bilateral lower limb IPC at 180 mmHg. Venous
blood samples were collected pre- and post-IPC to determine changes in plasma
nitrite [NO2-]. V[Combining Dot Above]O2 and
HR were continuously monitored during submaximal exercise.
RESULTS: Full arterial occlusion was confirmed via
coloured Doppler in all trials. Prior to IPC, plasma [NO2-]
was higher in DN (774 ± 179 nM, P=0.047) than BASE (576 ± 170 nM)
and PLA (544 ± 126 nM, P=0.752). Following IPC plasma [NO2-]
increased in PLA (Δ104 ± 149 nM, d=0.70) and DN (Δ42 ± 90 nM, d=0.47),
but not significantly (both P>0.2). In the DN trial, resting
V[Combining Dot Above]O2 was significantly lower compared to
BASE (314 ± 69 vs. 367 ± 30 mL/min, P=0.02) and tended to be lower
during exercise (P=0.066). Resting V[Combining Dot Above]O2 was
also lower in PLA than BASE (323 ± 62 mL/min, P=0.01) and during exercise (2783
± 262 vs. 3013 ± 342 mL/min, P=0.04). HR was not significantly
different in submaximal exercise (P=0.842). Completion time of TT was
not different between conditions (BASE: 1336 ± 73 s, PLA: 1344 ± 88 s, DN: 1344
± 76 s, P=0.69). Compared to BASE (171 ± 4 bpm), HR was lower
following DN (166 ± 4 bpm, P=0.02) but was not different in PLA
(169 ± 4 bpm, P=0.60).
CONCLUSION: In the present study, IPC with or without
DN, altered a number of physiological responses during rest and submaximal
exercise, potentially mediated by an increase in plasma [NO2-].
Despite this, there was no evidence for an additive effect and neither
intervention altered TT performance.
U2 - 10.1249/01.mss.0000485777.74366.23
DO - 10.1249/01.mss.0000485777.74366.23
M3 - Meeting abstract
SN - 0195-9131
VL - 48
SP - 258
JO - Medicine and Science in Sports and Exercise
JF - Medicine and Science in Sports and Exercise
IS - 5S
ER -